3 completed. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Antifibrinolytic Agents: new trials by email Literature Review of Antifibrinolytic Agents trials Research Report on Antifibrinolytic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks CCH-aaes, Antifibrinolytic Agent - Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 91 | 2022-06-15 | 2025-03-07 |
| Tranexamic Acid in Reverse Total Shoulder Arthroplasty Tranexamic Acid, Placebo - Shoulder Joint Disease, Complications; Arthroplasty | Phase 2 / Phase 3 | Completed | Corewell Health East | 116 | 2013-09-01 | 2017-06-19 |
| Tranexamic Acid in Pediatric Cardiac Surgery Tranexamic Acid - Blood Loss, Congenital Heart Disease | Not applicable | Completed | Okayama University | 160 | 2006-01-01 | 2009-10-14 |
Hemorrhage (2) · Arthritis (1) · Blood Loss, Surgical (1) · Cellulite (1) · Heart Defects, Congenital (1) · Intraoperative Complications (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Pathologic Processes (1) · Postoperative Complications (1) · Postoperative Hemorrhage (1)
Corewell Health East (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Okayama University (1)
United States (2)
David Hernandez (1) · Kevin Baker, PhD (1) · Michael J Wiater, M.D. (1) · Yuichiro Toda, MD, PhD (1)